news
UK regulator eyes AI scribes as medical devices, not just software
The UK's MHRA is exploring whether AI scribes, currently classified as software, should be regulated as medical devices. This move could bring stricter oversight for tools that capture and summarize clinical conversations. It's a big deal for health tech companies selling these tools across the pond.
The UK's MHRA is exploring whether AI scribes, currently classified as software, should be regulated as medical devices. This move could bring stricter oversight for tools that capture and summarize clinical conversations. It's a big deal for health tech companies selling these tools across the pond.
The architecture take
The UK is doing something smart here: looking past the "software" label and asking what these AI scribes do for a human nervous system. When an AI tool starts dictating how a doctor notes your symptoms or treatment plan, that's no longer just data entry. That's influencing clinical decision-making, which means it needs to be held to a higher standard of accuracy and safety. I'm glad someone's asking if these things could actually be messing with patient care or adding cognitive load. It's not about the code; it's about the downstream effect on human health, and that's exactly what medical device regulations are for. Watch for other regulators to follow this lead, because AI in healthcare isn't just an efficiency hack. It's a risk vector.